Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A study showed a 69% response rate for patients whose cancer carries the targeted mutation.
The approval will not only benefit current patients, but will also spur more research into the biology of other rare tumors.
Epithelioid sarcoma is a rare sub-type of soft tissue sarcoma that often occurs in young adults.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.